Outcome of infants exposed to olanzapine during breastfeeding

Breastfeeding Medicine

Volumn 6, Issue 2, 2011, Pages 55-58

  Gilad, Oded ^a   Merlob, Paul ^a,b,c   Stahl, Bracha ^b   Klinger, Gil ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; PARACETAMOL;

ADULT; ARTICLE; BIRTH DEFECT; BREAST FEEDING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG SAFETY; EVALUATION; FEEDING DISORDER; FEMALE; FOLLOW UP; HUMAN; INFANT; LACTATION; MOTOR RETARDATION; NEWBORN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; SPEECH DISORDER; STRUCTURED INTERVIEW; SYMPTOM; TELEPHONE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; WITHDRAWAL SYNDROME;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BREAST FEEDING; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT WELFARE; LACTATION; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MILK, HUMAN; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 79954497283     PISSN: 15568253     EISSN: None     Source Type: Journal    
DOI: 10.1089/bfm.2010.0027     Document Type: Article

References (17)

1. Pritchard DB, Harris B. Aspects of perinatal psychiatric ill-ness. Br J Psychiatry 1996;169:555-562.
2. Altshuler LL, Szuba MP. Course of psychiatric disorders in pregnancy: Dilemmas in pharmacologic management. Neu-rol Clin 1994;12:613-635. (Pubitemid 24279139)
3. Bymaster FP, Rasmussen K, Calligaro DO, et al. In vitro and in vivo biochemistry of olanzapine: A novel, atypical anti-psychotic drug. J Clin Psychiatry 1997;58(Suppl 10):28-36. (Pubitemid 27333178)
4. Reus VI. Olanzapine: A novel atypical neuroleptic agent. Lancet 1997;350:372.
5. McElroy SL, Frye M, Denicoff K, et al. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord 1998;49:119-122. (Pubitemid 28202001)
6. Goldstein DJ, Corbin LA, Fung MC. Olanzapine exposed pregnancies and lactation: Early experience. J Clin Psycho-pharmacol 2000;20:399-403. (Pubitemid 30463754)
7. Schaefer C, Ornoy A, Clementi M, et al. Using observational cohort data for studying drug effects on pregnancy outcome-methodological considerations. Reprod Toxicol 2008;26:36-41.
8. Goldstein LH, Berlin M, Tsur L, et al. The safety of macro-lides during lactation. Breastfeed Med 2009:4:197-200.
9. Goldstein DJ, Corbin LA, Wohlreich MM, et al. Olanzapine use during breast-feeding. Schizophr Res 2002;53:185.
10. Kirchheiner J, Berghofer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 2000;33:78-80. (Pubitemid 30161111)
11. Croke S, Buist A, Hackett LP, et al. Olanzapine excretion in human breast milk: Estimation of infant exposure. Int J Neuropsychopharmacol 2002;5:243-247.
12. Gardiner SJ, Kristensen JH, Begg EJ, et al. Transfer of olan-zapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. AmJPsychiatry 2003;160:1428-1431. (Pubitemid 41070917)
13. Freidman SH, Rosenthal MB. Treatment of perinatal delu-sional disorder: A case report. Int J Psychiatry Med 2003;33: 391-394. (Pubitemid 38580415)
14. Lutz UC, Wiatr G, Orlikowsky T, et al. Olanzapine treat-ment during breast feeding: A case report. Ther Drug Monit 2008;30:399-401.
15. Whitworth A, Stuppaeck C, Yazdi K, et al. Olanzapine and breast-feeding: Changes of plasma concentrations of olan-zapine in a breast-fed infant over a period of 5 months. J Psychcopharmacol 2010;24:121-123.
16. Bennet PN. Use of the monographs on drugs. In: Benet PN, ed. Drugs and Human Lactation. Elsevier, Amsterdam, 1996, pp. 67-74.
17. Aichhorn W, Yazdi K, Kralovec K, et al. Olanzapine plasma concentration in a newborn. J Psychopharmacol 2008;22: 923-924.